(Q34665186)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author

Eva Pers Winning Iepsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Julie Lundgren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Carsten Dirksen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jens-Erik Beck Jensen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Oluf Borbye Pedersen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Torben Hansen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sten Madsbad

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jens Juul Holst

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Signe Sørensen Torekov

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Benjamin A. H. Jensen

4

object named as

J-Eb Jensen

1 reference

3 August 2017

E W Iepsen

1

1 reference

PubMed ID

25287751

3 August 2017

S S Torekov

9

1 reference

PubMed ID

25287751

3 August 2017

language of work or name

English

0 references

publication date

7 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

834-841

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

20 February 2020

copyright license

start time

7 October 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/ijo.2014.177

0 references

cites work

Therapies for inter-relating diabetes and obesity - GLP-1 and obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Cardiometabolic risk after weight loss and subsequent weight regain in overweight and obese postmenopausal women

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Novel regulatory mechanisms for generation of the soluble leptin receptor: implications for leptin action

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Leptin reverses declines in satiation in weight-reduced obese humans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Effects of exenatide twice daily versus sitagliptin on 24-h glucose, glucoregulatory and hormonal measures: a randomized, double-blind, crossover study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Free leptin index as a marker for leptin action in diabetes and obesity: leptin and soluble leptin receptors relationship with HbA1c.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Adaptive thermogenesis in humans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Inhibition of food intake in obese subjects by peptide YY3-36

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Long-term persistence of hormonal adaptations to weight loss

7 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Comparing two low-energy diets for the treatment of knee osteoarthritis symptoms in obese patients: a pragmatic randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Lower leptin levels are associated with higher risk of weight gain over 2 years in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Evidence of an association between the Arg72 allele of the peptide YY and increased risk of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Liraglutide: short-lived effect on gastric emptying -- long lasting effects on body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Soluble Leptin Receptor Represents the Main Leptin Binding Activity in Human Blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

Circulating Soluble Leptin Receptor and Free Leptin Index during Childhood, Puberty, and Adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.177

GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours

9 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4424381

Quantification of the soluble leptin receptor in human blood by ligand-mediated immunofunctional assay

9 December 2018

1 reference

12 December 2020

Distribution and Immunocytochemical Colocalization of Peptide YY and Enteroglucagon in Endocrine Cells of the Rabbit Colon*

1 reference

12 December 2020

Leptin, soluble leptin receptors, free leptin index, and their relationship with insulin resistance and BMI: high normal BMI is the threshold for serum leptin increase in humans

1 reference

12 December 2020

GLP-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet

1 reference

12 December 2020

Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21

1 reference

12 December 2020

Identifiers

DOI

10.1038/IJO.2014.177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25287751%20AND%20SRC:MED&resulttype=core&format=json